The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Dopamine, learning and motivation.

Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ

Nolte, R. T., Wisely, G. B., Westin, S. K., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,955 · see citing works

Molecular Pathways of Neurodegeneration in Parkinson's Disease

Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,659 · see citing works

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

Kim, J., Auerbach, J. M., Rodríguez‐Gómez, J. A., Velasco, I., Gavin, D. K., Lumelsky, N. L., Lee, S., Nguyen, J., Sánchez‐Pernaute, R., Bankiewicz, K. S., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,598 · see citing works

Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid

Renaud, J., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/378681a0 · Cited by 1,098 · see citing works

Dopamine Neuron Agenesis in Nurr1-Deficient Mice

Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,096 · see citing works

Derivation of midbrain dopamine neurons from human embryonic stem cells

Perrier, A. L., Tabar, V. S., Barberi, T., Rubio, M. E., Brusés, J. L., Topf, N., Harrison, N. L., & Studer, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404700101 · Cited by 981 · see citing works

Parkinson’s Disease and Movement Disorders

Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 804 · see citing works

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

Cárdenas, O. S., Quintana-Hau, J. D. D., Le, W., Smidt, M. P., Cox, J. J., Mayo, F. J. D., Burbach, J. P. H., & Conneely, O. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4013 · Cited by 744 · see citing works

Pathology of Parkinson’s disease

Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 682 · see citing works

Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors

Wang, Z., Benoit, G., Liu, J., Prasad, S., Aarnisalo, P., Liu, X., Xu, H., Walker, N. P. C., & Perlmann, T. (2003) · Nature · doi:10.1038/nature01645 · Cited by 583 · see citing works

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

Gibb, W. R. G., & Lees, A. J. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574 · see citing works

Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells

Yan, Y., Yang, D., Żarnowska, E. D., Du, Z., Werbel, B., Valliere, C., Pearce, R. A., Thomson, J. A., & Zhang, S. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0365 · Cited by 489 · see citing works

Mutations in NR4A2 associated with familial Parkinson disease

Le, W., Xu, P., Jankovic, J. J., Jiang, H. F., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2002) · Nature Genetics · doi:10.1038/ng1066 · Cited by 488 · see citing works

Identification of a new brain-specific transcription factor, NURR1

Law, S. W. T., Conneely, O. M., DeMayo, F. J., & O’Malley, B. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1491694 · Cited by 399 · see citing works

A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b

Smidt, M. P., Asbreuk, C. H. J., Cox, J. J., Chen, H., Johnson, R. L., & Burbach, J. P. H. (2000) · Nature Neuroscience · doi:10.1038/73902 · Cited by 394 · see citing works

Pitx3 is required for development of substantia nigra dopaminergic neurons

Nunes, I., Tovmasian, L. T., Silva, R. M., Burke, R. E., & Goff, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230529100 · Cited by 385 · see citing works

Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a

Castelo‐Branco, G., Wagner, J., Rodríguez, F. J., Kele, J., Sousa, K. M., Rawal, N., Pasolli, H. A., Fuchs, E. V., Kitajewski, J., & Arenas, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534900100 · Cited by 367 · see citing works

Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain

Sakurada, K., Ohshima-Sakurada, M., Palmer, T. D., & Gage, F. H. (1999) · Development · doi:10.1242/dev.126.18.4017 · Cited by 359 · see citing works

Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system

Zetterström, R. H., Williams, R., Perlmann, T., & Olson, L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00074-5 · Cited by 340 · see citing works

Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons

van den Munckhof, P., Luk, K. C., Ste‐Marie, L., Montgomery, J. A., Blanchet, P. J., Sadikot, A. F., & Drouin, J. (2003) · Development · doi:10.1242/dev.00464 · Cited by 300 · see citing works

Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalamic Neurons in Mice with Targeted Disruption of the Nurr1 Gene

Castillo, S. O., Baffi, J., Palkovits, M., Goldstein, D. S., Kopin, I. J., Witta, J., Magnuson, M. A., & Nikodem, V. M. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0673 · Cited by 292 · see citing works

Parkinson's Disease and Movement Disorders

Jankovic, J. J., & Tolosa, E. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00637.x · Cited by 266 · see citing works

Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice

Hwang, D. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00162-1 · Cited by 257 · see citing works

Genetic clues to the pathogenesis of Parkinson's disease

Vila, M., & Przedborski, S. (2004) · Nature Medicine · doi:10.1038/nm1068 · Cited by 254 · see citing works

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons

Chung, S., Sonntag, K., Andersson, T., Björklund, L. M., Park, J., Kim, D., Kang, U. J., Ole Isacson, A., & Kim, K. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02255.x · Cited by 250 · see citing works

Nurr1 in Parkinson's disease and related disorders

Chu, Y., Le, W., Kompoliti, K., Jankovic, J. J., Mufson, E. J., & Kordower, J. H. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20828 · Cited by 227 · see citing works

Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism

Sacchetti, P., Mitchell, T. R., Granneman, J. G., & Bannon, M. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00181.x · Cited by 209 · see citing works

Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell‐specific manner

Kim, K., Kim, C., Hwang, D., Seo, H., Chung, S., Hong, S. J., Lim, J., Anderson, T., & Ole Isacson, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01671.x · Cited by 209 · see citing works

Age‐related decreases in Nurr1 immunoreactivity in the human substantia nigra

Chu, Y., Kompoliti, K., Cochran, E. J., Mufson, E. J., & Kordower, J. H. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10261 · Cited by 201 · see citing works

Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons

Smits, S. M., Ponnio, T., Conneely, O. M., Burbach, J. P. H., & Smidt, M. P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02885.x · Cited by 194 · see citing works

The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production

Bassett, M. H., Suzuki, T., Sasano, H., White, P. C., & Rainey, W. E. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0005 · Cited by 192 · see citing works

Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced Injury

Le, W. D., Conneely, O. M., He, Y., Jankovic, J. J., & Appel, S. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02218.x · Cited by 187 · see citing works

Neuroendocrine Regulation of the Hypothalamic Pituitary Adrenal Axis by the nurr1/nur77 Subfamily of Nuclear Receptors

Murphy, E. P., & Conneely, O. M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9874 · Cited by 183 · see citing works

The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells

Martínez‐González, J., & Badimón, L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.002 · Cited by 167 · see citing works

Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells

Hermanson, E. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00216-7 · Cited by 162 · see citing works

Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long term losses of dopamine neurons in offspring a potential new model of parkinson s disease

Carvey, P. M. (2003) · Frontiers in bioscience · doi:10.2741/1158 · Cited by 161 · see citing works

Age-dependent dopaminergic dysfunction in Nurr1 knockout mice

Jiang, C., Wan, X., He, Y., Pan, T., Jankovic, J. J., & Le, W. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.035 · Cited by 154 · see citing works

Co‐ordinate transcriptional regulation of dopamine synthesis genes by α‐synuclein in human neuroblastoma cell lines

Baptista, M. J., O’Farrell, C., Daya, S., Ahmad, R., Miller, D. W., Hardy, J., Farrer, M. J., & Cookson, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01742.x · Cited by 151 · see citing works

The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons

Chung, S., Hedlund, E., Hwang, M., Kim, D. W., Shin, B., Hwang, D., Kang, U. J., Ole Isacson, A., & Kim, K. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.09.008 · Cited by 151 · see citing works

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

Ai, Y., Markesbery, W. R., Zhang, Z., Grondin, R., Elseberry, D., Gerhardt, G. A., & Gash, D. M. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10689 · Cited by 149 · see citing works

Orphan Nuclear Receptor Nurr1 Is Essential for Ret Expression in Midbrain Dopamine Neurons and in the Brain Stem

Wallén‐Mackenzie, Å., Castro, D. S., Zetterström, R. H., Karlén, M., Olson, L., Ericson, J., & Perlmann, T. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1057 · Cited by 149 · see citing works

p57 Kip2 cooperates with Nurr1 in developing dopamine cells

Joseph, B., Wallén‐Mackenzie, Å., Benoit, G., Murata, T., Joodmardi, E., Okret, S., & Perlmann, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635658100 · Cited by 149 · see citing works

The NGFI-B subfamily of the nuclear receptor superfamily (review).

Maruyama, K., Tsukada, T., Ohkura, N., Bandoh, S., Hosono, T., & Yamaguchi, K. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.6.1237 · Cited by 144 · see citing works

BDNF Enhances the Functional Reinnervation of the Striatum by Grafted Fetal Dopamine Neurons

Yurek, D. M., Lu, W. Y.-R., Hipkens, S. B., & Wiegand, S. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0011 · Cited by 140 · see citing works

Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice

Le, W., Conneely, O. M., Zou, L., He, Y., Cárdenas, O. S., Jankovic, J. J., Mosier, D. R., & Appel, S. H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7191 · Cited by 139 · see citing works

Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cellsPreprint

Wallén‐Mackenzie, Å., de Urquiza, A. M., Petersson, S., Rodríguez, F. J., Friling, S., Wagner, J., Ordentlich, P., Lengqvist, J., Heyman, R. A., Arenas, E., et al. (2003) · Genes & Development · doi:10.1101/gad.276003 · Cited by 138 · see citing works

Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson’s disease

Xu, P., Liang, R., Jankovic, J. J., Hunter, C., Zeng, Y.-X., Ashizawa, T., Lai, D., & Le, W. (2002) · Neurology · doi:10.1212/wnl.58.6.881 · Cited by 118 · see citing works

A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain

Bäckman, C. M., Perlmann, T., Wallén‐Mackenzie, Å., Hoffer, B. J., & Morales, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02149-6 · Cited by 117 · see citing works

Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers

Bannon, M. J., Pruetz, B., Manning-Bog, A., Whitty, C. J., Michelhaugh, S. K., Sacchetti, P., Granneman, J. G., Mash, D. C., & Schmidt, C. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092654299 · Cited by 109 · see citing works

Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system

Cárdenas, O. S., & Conneely, O. M. (1996) · Journal of Molecular Neuroscience · doi:10.1007/bf02736848 · Cited by 106 · see citing works

A Common NURR1 Polymorphism Associated With Parkinson Disease and Diffuse Lewy Body Disease

Zheng, K., Heydari, B., & Simon, D. K. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.722 · Cited by 100 · see citing works

NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3

Mages, H. W., Rilke, O., Bravo, R., Senger, G., & Kroczek, R. A. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.11.7877627 · Cited by 97 · see citing works

Molecular mechanisms underlying midbrain dopamine neuron development and function

Smidt, M. P., Smits, S. M., & Burbach, J. P. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.094 · Cited by 93 · see citing works

Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity

Eells, J. B., Lipska, B. K., Yeung, S. K., Misler, J. A., & Nikodem, V. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00185-7 · Cited by 92 · see citing works

Progression of Parkinson Disease

Jankovic, J. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.351 · Cited by 84 · see citing works

Parathyroid Hormone Induces Expression of the Nuclear Orphan Receptor Nurr1 in Bone Cells**This work was supported by NIH Grant R-01-DE-13316.

Tetradis, S., Bezouglaia, O., & Tsingotjidou, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7926 · Cited by 79 · see citing works

4.5 kb of the rat tyrosine hydroxylase 5′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors

Schimmel, J. J., Crews, L., Roffler-Tarlov, S. K., & Chikaraishi, D. M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00234-x · Cited by 76 · see citing works

Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-?

Roussa, E., & KRIEGLSTEIN, K. G. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0916-4 · Cited by 73 · see citing works

Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor, NURR1

Cárdenas, O. S., Kardon, R., Ediger, T. R., Lydon, J. P., & Conneely, O. M. (1997) · Gene · doi:10.1016/s0378-1119(96)00736-6 · Cited by 72 · see citing works

Extended mutation analysis and association studies of Nurr1 ( NR4A2 ) in Parkinson disease

Hering, R., Petrovic, S., Mietz, E.-M., Holzmann, C., Berg, D., Bauer, P., Woitalla, D., Müller, T., Berger, K., Krüger, R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000118285.18383.90 · Cited by 62 · see citing works

GDNF promotes neuronal differentiation and dopaminergic development of mouse mesencephalic neurospheres

Roussa, E., & KRIEGLSTEIN, K. G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.106 · Cited by 60 · see citing works

Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs

Ichinose, H., Ohye, T., Suzuki, T., Sumi‐Ichinose, C., Nomura, T., Hagino, Y., & Nagatsu, T. (1999) · Gene · doi:10.1016/s0378-1119(99)00065-7 · Cited by 55 · see citing works

Organization of central nervous system dopaminergic pathways.

Albanese, A., Altavista, M. C., & Rossi, P. (1986) · PubMed · Cited by 54 · see citing works

Parkinson’s Disease and Related Disorders

Riederer, P., Youdim, M. B. H., Reichmann, H., & Gerlach, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0 · Cited by 54 · see citing works

Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts

Pirih, F. Q. M., Tang, A., Ozkurt, I. C., Nervina, J. M., & Tetradis, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405677200 · Cited by 52 · see citing works

Requirements for Heterodimerization between the Orphan Nuclear Receptor Nurr1 and Retinoid X Receptors

Sacchetti, P., Dwornik, H., Formstecher, P., Rachez, C., & Lefèbvre, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205816200 · Cited by 50 · see citing works

NR4A2 mutations are rare among European patients with familial Parkinson's disease

Wellenbrock, C., Hedrich, K., Schäfer, N., Kasten, M., Jacobs, H., SCHWINGER, E., Hagenah, J. M., Pramstaller, P. P., Vieregge, P., & Klein, C. (2003) · Annals of Neurology · doi:10.1002/ana.10736 · Cited by 48 · see citing works

Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons

Grothe, C., Timmer, M., Scholz, T., Winkler, C., Nikkhah, G., Claus, P., Itoh, N., & Arenas, E. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.007 · Cited by 46 · see citing works

NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits

Carmine, A., Buervenich, S., Galter, D., Jönsson, E. G., Sedvall, G. C., Farde, L., Gustavsson, P. J., Bergman, H., Chowdari, K. V., Nimgaonkar, V. L., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20033 · Cited by 44 · see citing works

Organization of the human orphan nuclear receptor Nurr1 gene

Torii, T., Kawarai, T., Nakamura, S., & Kawakami, H. (1999) · Gene · doi:10.1016/s0378-1119(99)00064-5 · Cited by 44 · see citing works

Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection

Pan, T., Xie, W., Jankovic, J. J., & Le, W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.080 · Cited by 42 · see citing works

Development of the dopaminergic neurons in the rodent brainstem

Vitalis, T., Cases, O., & Parnavelas, J. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.044 · Cited by 41 · see citing works

Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and nurr1-deficient mice

Baffi, J., Palkovits, M., Castillo, S. O., Mezey, É., & Nikodem, V. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00124-4 · Cited by 41 · see citing works

Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins

Lee, M. A., Lee, H.-S., Lee, H. S., Cho, K. G., Jin, B. K., Sohn, S., Lee, Y. S., Ichinose, H., & Kim, S. U. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00981-3 · Cited by 40 · see citing works

Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1

Nordzell, M., Aarnisalo, P., Benoit, G., Castro, D. S., & Perlmann, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.079 · Cited by 38 · see citing works

Genetic analysis of Nurr1 haplotypes in Parkinson's disease

Tan, E.-K., Chung, H., Zhao, Y., Shen, H., Chandran, V. R., Tan, C., Teoh, M., Yih, Y., Ratnagopal, P., & Wong, M.-C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00539-1 · Cited by 32 · see citing works

Lyme disease and related disorders.

Stanek, G. (1985) · PubMed · Cited by 32 · see citing works

Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine

Bäckman, C. M., You, Z., Perlmann, T., & Hoffer, B. J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00029-9 · Cited by 28 · see citing works

Chronic lithium decreases Nurr1 expression in the rat brain and impairs spatial discrimination

Albanchaabouchi, M., de Ortı́z, S. P., MENENDEZ, R., Ren, K., & Maldonado-Vlaar, C. S. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.015 · Cited by 26 · see citing works

Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice

Tseng, K. Y., Roubert, C., Do, L., Rubinstein, M., Kelly, M. A., Grandy, D. K., Low, M. J., Gershanik, O. S., Murer, M. G., Bruno Giros, A., et al. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00107-8 · Cited by 21 · see citing works

Neurodegenerative Disease

Michalos, A. C. (2014) · Springer eBooks · doi:10.1007/978-94-007-0753-5_102720 · Cited by 20 · see citing works

Identification of Nuclear Orphan Receptors as Regulators of Expression of a Neurotransmitter Receptor Gene

Chew, L., Huang, F., Boutin, J., & Gallo, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29366 · Cited by 19 · see citing works

Parathyroid Hormone Induces Expression of the Nuclear Orphan Receptor Nurr1 in Bone Cells

Tetradis, S. (2001) · Endocrinology · doi:10.1210/en.142.2.663 · Cited by 15 · see citing works

Novel splicing variant of the human orphan nuclear receptor Nurr1 gene.

Xu, P., & Le, W. D. (2004) · PubMed · Cited by 8 · see citing works

Untitled work

Jonnal (2000) · doi:10.1002/1096-8628(20001204)96:6

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

Duty, S., & Jenner, P. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 758 · see citing works

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 534 · see citing works

Parkinson’s disease: animal models and dopaminergic cell vulnerability

Blesa, J., & Przedborski, S. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00155 · Cited by 483 · see citing works

Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons

Kadkhodaei, B., Ito, T., Joodmardi, E., Mattsson, B., Rouillard, C., Carta, M., Muramatsu, S.-I., Sumi-Ichinose, C., Nomura, T., Metzger, D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3910-09.2009 · Cited by 382 · see citing works

How to make a midbrain dopaminergic neuron

Arenas, E., Denham, M., & Villaescusa, C. (2015) · Development · doi:10.1242/dev.097394 · Cited by 306 · see citing works

Methylomic trajectories across human fetal brain development

Spiers, H., Hannon, E., Schalkwyk, L. C., Smith, R., Wong, C. C. Y., O’Donovan, M. C., Bray, N. J., & Mill, J. (2015) · Genome Research · doi:10.1101/gr.180273.114 · Cited by 287 · see citing works

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons

Decressac, M., Mattsson, B., Lundblad, M., Weikop, P., & Björklund, A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.013 · Cited by 286 · see citing works

To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models

Meyer, U., & Feldon, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.009 · Cited by 247 · see citing works

Vitamin D and the brain: Genomic and non-genomic actions

Cui, X., Gooch, H. M., Petty, A. E., McGrath, J. J., & Eyles, D. W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.035 · Cited by 250 · see citing works

Astrocytes and Therapeutics for Parkinson's Disease

Rappold, P. M., & Tieu, K. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.001 · Cited by 228 · see citing works

Animal models of Parkinson's disease

Jackson-Lewis, V. R., Blesa, J., & Przedborski, S. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70057-8 · Cited by 193 · see citing works

Gene Therapy for Parkinson’s Disease, An Update

Axelsen, T. M., & Woldbye, D. P. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181331 · Cited by 175 · see citing works

miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression

Yang, D., Li, T., Wang, Y., Tang, Y., Cui, H., Tang, Y., Zhang, X., Chen, D., Shen, N., & Le, W. (2012) · Journal of Cell Science · doi:10.1242/jcs.086421 · Cited by 154 · see citing works

Decreased NURR1 gene expression in patients with Parkinson's disease

Le, W., Pan, T., Huang, M., Xu, P., Xie, W., Zhu, W., Zhang, X., Deng, H., & Jankovic, J. J. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.007 · Cited by 145 · see citing works

Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits

Schultheis, P. J., Fleming, S. M., Clippinger, A. K., Lewis, J. M., Tsunemi, T., Giasson, B. I., Dickson, D. W., Mazzulli, J. R., Bardgett, M. E., Haik, K. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt057 · Cited by 144 · see citing works

Therapeutic prospects for Parkinson disease

Olanow, C. W., & Schapira, A. H. V. (2013) · Annals of Neurology · doi:10.1002/ana.24011 · Cited by 140 · see citing works

Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine

Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138 · see citing works

Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells

Sharma, R., Ottenhof, T., Rzeczkowska, P. A., & Niles, L. P. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00587.x · Cited by 136 · see citing works

The importance of Wnt signalling for neurodegeneration in Parkinson's disease

Berwick, D. C., & Harvey, K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120122 · Cited by 131 · see citing works

Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?

Ogundare, M., Theofilopoulos, S., Lockhart, A., Hall, L. J., Arenas, E., Sjövall, J., Brenton, A. G., Wang, Y., & Griffiths, W. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086678 · Cited by 128 · see citing works

Prenatal Immune Activation Interacts with Genetic<i>Nurr1</i>Deficiency in the Development of Attentional Impairments

Vuillermot, S., Joodmardi, E., Perlmann, T., Ove Ögren, S., Feldon, J., & Meyer, U. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4831-11.2012 · Cited by 127 · see citing works

Animal models of Parkinson's disease: An updated overview

Gubellini, P., & Kachidian, P. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.011 · Cited by 121 · see citing works

Epigenetic mechanisms in Parkinson's disease

Feng, Y., Jankovic, J. J., & Wu, Y. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.017 · Cited by 120 · see citing works

Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP

Di Salvio, M., Di Giovannantonio, L. G., Acampora, D., Prosperi, R., Omodei, D., Prakash, N., Wurst, W., & Simeone, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2661 · Cited by 118 · see citing works

Nurr1‐Based Therapies for Parkinson's Disease

Dong, J., Li, S., Mo, J., Cai, H., & Le, W. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12536 · Cited by 115 · see citing works

Differential expression of dopaminergic cell markers in the adult zebrafish forebrain

Yamamoto, K., Ruuskanen, J. O., Wullimann, M. F., & Vernier, P. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22535 · Cited by 113 · see citing works

Protective Microglia and Their Regulation in Parkinson’s Disease

Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112 · see citing works

Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes

Chu, Y., Muller, S., Tavares, A., Barret, O., Alagille, D., Seibyl, J. P., Tamagnan, G. D., MAREK, K. L., Luk, K. C., Trojanowski, J. Q., et al. (2019) · Brain · doi:10.1093/brain/awz296 · Cited by 112 · see citing works

Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for Parkinsonian rats

Fujii, H., Matsubara, K., Sakai, K., Ito, M., Ohno, K., Ueda, M., & Yamamoto, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.001 · Cited by 110 · see citing works

Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death

Jakaria, M., Haque, M. E., Cho, D.-Y., Azam, S., Kim, I., & Choi, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1487-4 · Cited by 109 · see citing works

Functional models of Parkinson's disease: A valuable tool in the development of novel therapies

Jenner, P. G. (2009) · Annals of Neurology · doi:10.1002/ana.21489 · Cited by 107 · see citing works

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

Heiman, M., Heilbut, A. M., Francardo, V., Kulicke, R., Fenster, R. J., Kolaczyk, E. D., Mesirov, J. P., Surmeier, D. J., Cenci, M. A., & Greengard, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401819111 · Cited by 106 · see citing works

Animal Models of Parkinson's Disease: A Gateway to Therapeutics?

Le, W., Sayana, P., & Jankovic, J. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0234-1 · Cited by 106 · see citing works

Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease

Xie, W., Li, X., Li, C., Zhu, W., Jankovic, J. J., & Le, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06914.x · Cited by 105 · see citing works

Inflammatory response in Parkinson’s disease (Review)

Yan, J., Fu, Q., Cheng, L.-N., ZHAI, M., Wu, W., Huang, L., & Du, G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2563 · Cited by 101 · see citing works

Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro

Volpicelli, F., Caiazzo, M., Greco, D., Consales, C., Leone, L., Perrone‐Capano, C., D’Amato, L. C., & di Porzio, U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04494.x · Cited by 100 · see citing works

Genetic factors and manganese-induced neurotoxicity

Chen, P., Parmalee, N. L., & Aschner, M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00265 · Cited by 98 · see citing works

Induction of Human Mesenchymal Stem Cells into Dopamine-Producing Cells with Different Differentiation Protocols

Barzilay, R., Kan, I., Ben‐Zur, T., Bulvik, S., Melamed, E., & Offen, D. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0172 · Cited by 94 · see citing works

Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke

Hara, K., Yasuhara, T., Maki, M., Matsukawa, N., MASUDA, T., Yu, S. J., Ali, M. S., Yu, G., Xu, L., & Kim, S. U. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.005 · Cited by 93 · see citing works

The Nuclear Receptor Field: A Historical Overview and Future Challenges

Mazaira, G. I., Zgajnar, N. R., Lotufo, C. M., Daneri-Becerra, C., Sivils, J. C., Soto, O. B., Cox, M. B., & Galigniana, M. D. (2018) · Nuclear Receptor Research · doi:10.11131/2018/101320 · Cited by 92 · see citing works

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease

Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 94 · see citing works

MANF regulates dopaminergic neuron development in larval zebrafish

Chen, Y.-C., Sundvik, M., Rozov, S. V., Priyadarshini, M., & Panula, P. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.07.030 · Cited by 91 · see citing works

Experimental models of Parkinson's disease: Challenges and Opportunities

Lal, R., Singh, A., watts, S., & Chopra, K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176819 · Cited by 90 · see citing works

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease

Esteves, M., Cristóvão, A. C., Saraiva, T., Rocha, S. M., Baltazar, G., Ferreira, L., & Bernardino, L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00020 · Cited by 88 · see citing works

Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells

Shao, Q.-H., Yan, W.-F., Zhang, Z., Ma, K., Peng, S.-Y., Cao, Y., Yuan, Y., & Chen, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.008 · Cited by 87 · see citing works

Orphan nuclear receptors in drug discovery

Shi, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.04.006 · Cited by 85 · see citing works

Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment

Wei, X., Gao, H., Zou, J., Liu, X., Chen, D., Liao, J., Xu, Y., Ma, L., Tang, B., Zhang, Z., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9477-7 · Cited by 84 · see citing works

Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease

Macchi, B., Paola, R. D., Marino‐Merlo, F., Felice, M. R., Cuzzocrea, S., & Mastino, A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150225124928 · Cited by 80 · see citing works

Epigenetics in Parkinson’s Disease

Pavlou, M. A. S., & Outeiro, T. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_19 · Cited by 81 · see citing works

Knockdown of Nurr1 in the rat hippocampus: Implications to spatial discrimination learning and memoryPreprint

Colón, W. I., Martínez, M., Morales, S., Félix, J., Cruz, J., Adorno, M., Pereira, L., Colón, N., Maldonado-Vlaar, C. S., & de Ortı́z, S. P. (2006) · Learning & Memory · doi:10.1101/lm.407706 · Cited by 81 · see citing works

A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)

Smith, G. A., Rocha, E. M., Rooney, T., Barnéoud, P., McLean, J. R., Beagan, J. A., Osborn, T. M., Coimbra, M., Luo, Y., Hallett, P. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121072 · Cited by 78 · see citing works

Etiopathogenesis of Parkinson Disease: A New Beginning?

Le, W., Chen, S., & Jankovic, J. J. (2008) · The Neuroscientist · doi:10.1177/1073858408319974 · Cited by 77 · see citing works

Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite

Bruning, J. M., Wang, Y., Oltrabella, F., Tian, B., Kholodar, S. A., Liu, H., Bhattacharya, P., Guo, S., Holton, J. M., Fletterick, R. J., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.002 · Cited by 78 · see citing works

The regulation and deregulation of Wnt signaling by PARK genes in health and disease

Berwick, D. C., & Harvey, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt037 · Cited by 75 · see citing works

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review

Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G., & Piperi, C. (2022) · Brain Sciences · doi:10.3390/brainsci12020175 · Cited by 73 · see citing works

Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson’s Disease: Potential Disease Biomarkers

Yang, Z., Li, T., Li, S., Wei, M., Qi, H., Shen, B., Chang, R. C., Le, W., & Piao, F. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00460 · Cited by 72 · see citing works

VMAT2 gene expression and function as it applies to imaging β-cell mass

Harris, P. E., Ferrara, C., Barba, P., Polito, T., Freeby, M., & Maffei, A. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0242-x · Cited by 68 · see citing works

NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain

Blin, M., Norton, W., Bally‐Cuif, L., & Vernier, P. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.08.006 · Cited by 66 · see citing works

Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease

Zhang, L., Le, W., Xie, W., & Dani, J. A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.022 · Cited by 65 · see citing works

Neurobehavioral and transcriptional effects of acrylamide in juvenile rats

Seale, S., Feng, Q. F., Agarwal, A. K., & El‐Alfy, A. T. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.006 · Cited by 64 · see citing works

Nuclear Import and Export Signals Control the Subcellular Localization of Nurr1 Protein in Response to Oxidative Stress*

García‐Yagüe, Á. J., Rada, P., Rojo, A. I., Lastres‐Becker, I., & Cuadrado, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.439190 · Cited by 64 · see citing works

Genetic Testing in Parkinson Disease

Tan, E., & Jankovic, J. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1232 · Cited by 64 · see citing works

Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model

Kim, N. K., Choi, B. H., Huang, X., Snyder, B., Bukhari, S., Kong, T., Park, H., Park, H. C., Park, S. R., & Ha, Y. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06653.x · Cited by 62 · see citing works

Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, l-DOPA Responsivity, and Glutamatergic Neurotransmission

Alvarsson, A., Zhang, X., Stan, T. L., Schintu, N., Kadkhodaei, B., Millan, M. J., Perlmann, T., & Svenningsson, P. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1312-15.2015 · Cited by 62 · see citing works

Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson’s Disease in a Mouse Model

Jia, E., Zhou, Y., Liu, Z., Wang, L., Ouyang, T., Pan, M., Bai, Y., & Ge, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083006 · Cited by 62 · see citing works

Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson’s disease

Liu, H., Wei, L., Tao, Q., Deng, H., Ming, M., Xu, P., & Le, W. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03644.x · Cited by 60 · see citing works

LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features

Villalonga-Rosso, E., Mosrin-Huaman, C., Normand, T., Girardin, C., Serrano, A., Žunar, B., Doudeau, M., Godin, F., Bénédetti, H., & Vallée, B. (2023) · Cells · doi:10.3390/cells12050805 · Cited by 59 · see citing works

Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA

Wang, T. T., Tio, M., Lee, W., Beerheide, W., & Udolph, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.046 · Cited by 59 · see citing works

NR4A2 protects cardiomyocytes against myocardial infarction injury by promoting autophagy

Liu, H., Liu, P., Shi, X.-X., Yin, D., & Zhao, J. (2018) · Cell Death Discovery · doi:10.1038/s41420-017-0011-8 · Cited by 58 · see citing works

Omega-3 Deficiency and Neurodegeneration in the Substantia Nigra: Involvement of Increased Nitric Oxide Production and Reduced BDNF Expression

Cardoso, H. D., Santos Junior, E. F. D., de Santana, D. F., Gonçalves-Pimentel, C., Angelim, M. K., Isaac, A. R., Lagranha, C. J., Guedes, R. C. A., Beltrão, E. I., Morya, E., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.023 · Cited by 55 · see citing works

The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed

Alavian, K. N., Jeddi, S., Naghipour, S. I., Nabili, P., Licznerski, P., & Tierney, T. S. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-27 · Cited by 53 · see citing works

The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis

Jeon, S. G., Yoo, A., Chun, D. W., Hong, S. B., Chung, H., Kim, J.-I., & Moon, M. (2020) · Aging and Disease · doi:10.14336/ad.2019.0718 · Cited by 55 · see citing works

The role of NURR1 in metabolic abnormalities of Parkinson’s disease

Al‐Nusaif, M., Yang, Y., Li, S., Cheng, C., & Le, W. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00544-w · Cited by 52 · see citing works

An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases

Batistela, M. S., Josviak, N. D., Sulzbach, C. D., & de Souza, R. L. R. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1209754 · Cited by 52 · see citing works

Genetics of Parkinson’s disease and parkinsonism

Douglas, M. R., Lewthwaite, A. J., & Nicholl, D. J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.657 · Cited by 52 · see citing works

In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine‐associated genes into neuron‐like cells

Fallahi‐Sichani, M., Soleimani, M., Najafi, S. M. A., Kiani, J., Arefian, E., & Atashi, A. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.011 · Cited by 52 · see citing works

A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro

Hammond, S. L., Safe, S. H., & Tjalkens, R. B. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.09.015 · Cited by 51 · see citing works

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 53 · see citing works

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model

Cho, E., Zaremba, J. D., McKercher, S. R., Talantova, M. V., Tu, S., Masliah, E., Chan, S. F., Nakanishi, N., Terskikh, A. V., & Lipton, S. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024027 · Cited by 49 · see citing works

Nuclear Receptor Unfulfilled Regulates Axonal Guidance and Cell Identity of Drosophila Mushroom Body Neurons

Lin, S., Huang, Y., & Lee, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008392 · Cited by 50 · see citing works

Developmental single-cell transcriptomics of hypothalamic POMC neurons reveal the genetic trajectories of multiple neuropeptidergic phenotypes

Yu, H., Rubinstein, M., & Low, M. J. (2022) · eLife · doi:10.7554/elife.72883 · Cited by 53 · see citing works

Dopamine Genes and Nicotine Dependence in Treatment-Seeking and Community Smokers

Bergen, A. W., Conti, D. V., Berg, D. V. D., Lee, W., Liu, J., Li, D., Guo, N., Mi, H., Thomas, P. D., Lessov‐Schlaggar, C. N., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.52 · Cited by 49 · see citing works

Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons

Heng, X., Jin, G., Zhang, X., Yang, D., Zhu, M., Fu, S., Li, X., & Le, W. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-4 · Cited by 48 · see citing works

Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction

Zhang, L., Cen, L., Qu, S., Wei, L., Mo, M., Feng, J., Sun, C., Xiao, Y., Luo, Q., Li, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152931 · Cited by 48 · see citing works

Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside

Wang, M., Ling, K., Tan, J. J., & Lu, C. (2020) · Cells · doi:10.3390/cells9061489 · Cited by 46 · see citing works

Signaling of Glial Cell Line-Derived Neurotrophic Factor and Its Receptor GFRα1 Induce Nurr1 and Pitx3 to Promote Survival of Grafted Midbrain-Derived Neural Stem Cells in a Rat Model of Parkinson Disease

Lei, Z., Jiang, Y., Li, T., Zhu, J., & Shuilin, Z. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822830e5 · Cited by 47 · see citing works

Emerging roles of epigenetic mechanisms in Parkinson’s disease

Habibi, E., Masoudi‐Nejad, A., Abdolmaleky, H. M., & Haggarty, S. J. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0246-z · Cited by 46 · see citing works

A Nurr1 point mutant, implicated in Parkinson’s disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription

Jacobsen, K. X., MacDonald, H. R., Lemonde, S., Daigle, M., Grimes, D. A., Bulman, D. E., & Albert, P. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.003 · Cited by 46 · see citing works

Bisphenol A exposure induces neurobehavioral deficits and neurodegeneration through induction of oxidative stress and activated caspase‐3 expression in zebrafish brain

Sahoo, P. K., Aparna, S., Naik, P. K., Singh, S. B., & Das, S. K. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22873 · Cited by 45 · see citing works

Nurr1 transcriptionally regulates the expression of α-synuclein

Yang, Y. X., & Latchman, D. S. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3282ffda48 · Cited by 45 · see citing works

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency

Vuillermot, S., Joodmardi, E., Perlmann, T., Ögren, S. O., Feldon, J., & Meyer, U. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00698.x · Cited by 44 · see citing works

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease

Maguire‐Zeiss, K. A., & Federoff, H. J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0431-6 · Cited by 44 · see citing works

An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function

Laar, A. D. V., Laar, V. S. V., Sebastián, W. S., Merola, A., Elder, J. B., Lonser, R. R., & Bankiewicz, K. S. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212724 · Cited by 44 · see citing works

Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration

D’Anca, M., Buccellato, F. R., Fenoglio, C., & Galimberti, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084134 · Cited by 44 · see citing works

Intergenerational Effect of Early Life Exposure to Permethrin: Changes in Global DNA Methylation and in Nurr1 Gene Expression

Bordoni, L., Nasuti, C., Mirto, M., Caradonna, F., & Gabbianelli, R. (2015) · Toxics · doi:10.3390/toxics3040451 · Cited by 43 · see citing works

Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia

Chen, X., Yuan, Q., Wang, X., Tang, Z., Xu, J., Lin, H. Y., Yang, Z., Song, X., Lü, D., Guo, J., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12825 · Cited by 43 · see citing works

Epigenetic Response to Mindfulness in Peripheral Blood Leukocytes Involves Genes Linked to Common Human Diseases

García-Campayo, J., Puebla-Guedea, M., Labarga, A., Urdánoz, A., Roldán, M., Pulido, L., de Morentin, X. M., Perdones-Montero, Á., Montero-Marín, J., & Mendioroz, M. (2018) · Mindfulness · doi:10.1007/s12671-017-0851-6 · Cited by 42 · see citing works

Transcription factor PITX3 gene in Parkinson's disease

Le, W., Nguyen, D. K., Lin, X. W., Rawal, P., Huang, M., Ding, Y., Xie, W., Deng, H., & Jankovic, J. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.015 · Cited by 42 · see citing works

p38 MAPKs regulate the expression of genes in the dopamine synthesis pathway through phosphorylation of NR4A nuclear receptors

Sekine, Y., Takagahara, S., Hatanaka, R., Watanabe, T., Oguchi, H., Noguchi, T., Naguro, I., Kobayashi, K., Tsunoda, M., Funatsu, T., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.085902 · Cited by 42 · see citing works

New and emerging medical therapies in Parkinson’s disease

Lotia, M., & Jankovic, J. J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1149163 · Cited by 41 · see citing works

Nurr1: A New Insight to Protects Dopaminergic Neurodegeneration in Parkinson’s disease

(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.436 · Cited by 1 · see citing works

Transcription factor Nurr1 in dopamine neuron development and neurodegeneration associated with Parkinson's disease

Le, W. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.06.122

Nurr1 in Parkinson's disease and related disorders

Chu, Y., Le, W., Kompoliti, K., Jankovic, J. J., Mufson, E. J., & Kordower, J. H. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20828 · Cited by 227 · see citing works

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential

Decressac, M., Volakakis, N., Björklund, A., & Perlmann, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.209 · Cited by 234 · see citing works

Dopamine Neuron Agenesis in Nurr1-Deficient Mice

Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,096 · see citing works